The global melanocyte protein PMEL market is anticipated to grow at a significant CAGR during the forecast period (2021-2027). Melanocyte protein PMEL is also known as premelanosome protein (PMEL) or silver locus protein homolog (SILV). It is a protein that is encoded by the PMEL gene in humans. The major factor driving the growth of the market include the rising prevalence of melanoma across the globe. According to the American Cancer Society, in 2022, an estimated 99,780 new melanomas will be diagnosed globally. Out of which about 57,180 new cases will be diagnosed in men and 42,600 in women.
To Request a Sample of our Report on Melanocyte Protein PMEL Market: https://www.omrglobal.com/request-sample/melanocyte-protein-pmel-market
Additionally, the risk of melanoma increases with age. Further, 65 years is the average age of people when it is diagnosed. However, melanoma can also occur among people under 30 years of age. It is also one of the most common cancers in young adults. Although, it is more common in men, however, the rates are higher in women than in men before 50 years of age. Apart from this, this protein plays an important role during pigment formation and eumelanosome development. It is also used as a melanoma tumour marker owing to its assumed melanocyte-specific expression at the protein level. Hence, the increasing prevalence of melanoma is driving the growth of the global melanocyte protein PMEL Market. Moreover, North America is anticipated to hold a prominent share in the market due to the presence of a high rate of melanoma tumor coupled with advanced healthcare infrastructure.
Market Coverage
- The market number available for – 2020-2027
- Base year- 2020
- Forecast period- 2021-2027
Segment Covered-
- By Type
- By Application
Regions Covered-
- North America
- Europe
- Asia-Pacific
- Rest of the World
Competitive Landscape– ImmunoCellular Therapeutics, Ltd., and Vault Pharma Inc., among others.
(Get 15% Discount on Buying this Report)
A full Report of Melanocyte Protein PMEL Market is Available @ https://www.omrglobal.com/industry-reports/melanocyte-protein-pmel-market
Global Melanocyte Protein PMEL Market Report by Segment
By Type
- AE-M vaccine
- SCIB-1
- VPI-121
- Others
By Application
- Glioblastoma Multiforme
- Melanoma
- Metastatic Melanoma
Global Melanocyte Protein PMEL Market Report by Region
North America
- United States
- Canada
Europe
- UK
- Germany
- Spain
- France
- Italy
- Rest of Europe
Asia-Pacific
- India
- China
- Japan
- South Korea
- Rest of APAC
Rest of the World
- Latin America
- Middle East & Africa
Reasons to buy from us –
- We cover more than 15 major industries, further segmented into more than 90 sectors.
- More than 120 countries are for analysis.
- Over 100+ paid data sources mined for investigation.
- Our expert research analysts answer all your questions before and after purchasing your report.
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.
Media Contact:
Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact no: +91 7803040404
